Novo Nordisk A/S (NVO)
Novo Nordisk A/S ROIC - WACC
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC - WACC | 9.7% | 12.4% | 12.9% | 12.7% | 20.4% | 26.6% | 34.4% | 38.1% | 49.1% | 52.5% | 54.5% | 75.4% | 60.5% | 50.3% | 43.3% | 42.4% | 36.4% | 30.1% | 29.1% | 32.0% |
Novo Nordisk A/S (NVO) ROIC - WACC comparison analysis
NVO key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Novo Nordisk A/S's ROIC - WACC?
As of today, Microsoft Corp's last 12-month ROIC - WACC is 35.9%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual ROIC - WACC for Novo Nordisk A/S have been 28.8% over the past three years, and 32.9% over the past five years.
2) Is Novo Nordisk A/S's ROIC - WACC Good?
As of today, Novo Nordisk A/S's ROIC - WACC is 35.9%, which is higher than industry median of (127.8%). It indicates that Novo Nordisk A/S's ROIC - WACC is Good.